Influence of Ukrain on DNA, RNA and protein synthesis in malignant cells

Drugs under Experimental and Clinical Research

Volumn 22, Issue 3-5, 1996, Pages 81-91

  Nowicky, J W ^a   Hiesmayr, W ^a   Nowicky, W ^a   Liepins, A ^b  

^a Ukrainian Anti Cancer Institute   (Austria)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; THYMIDINE; UKRAIN; URIDINE;

ANIMAL CELL; ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; GUINEA PIG; HELA CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIVER CELL; LYMPHOMA; MOUSE; MYELOMA; NONHUMAN; PROTEIN SYNTHESIS; RNA SYNTHESIS; TONSIL; YOSHIDA SARCOMA;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; BERBERINE ALKALOIDS; DNA, NEOPLASM; GUINEA PIGS; HELA CELLS; HUMANS; LIVER; LYMPHOMA; MICE; MULTIPLE MYELOMA; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; PHENANTHRIDINES; RNA, NEOPLASM; SARCOMA, YOSHIDA; TONSIL;

EID: 0029812390     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Nowicky J.W., Nowicky W., Liepins A. Cytostatic and cytotoxic effects of Ukrain on malignant cells. V Mediterranean Congress of Chemotherapy, 24-29 May 1992, Athens, Greece. J. Chemioterapia, 5, (Suppl. 1), 797, 1993.
2. Nowicky J.W., Liepins A., Staniszweski A., Slesak B., Nowicky W., Hiesmayr W. The malignotoxic and immune modulating property of the alkaloid derivative Ukrain. J. Cancer Res. Clin. Oncol. 118 (Suppl.), V1.09.05, 1992.
3. Liepins A., Nowicky J.W. Selective induction of programmed cell death (apoptosis) in malignant cells by the alkaloid derivative Ukrain (NSC 631570). 11th Future Trends in Chemotherapy, Interdisciplinary World Congress on Antimicrobial and Anticancer Drugs, 25-27 April 1994, Geneva, Switzerland (Abstract 93).
4. Staniszewski A., Slesak B., Kolodziej J., Harlozinska-Smyrka A. Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain). Drugs Exptl. Clin. RBS., XVIII (Suppl.), 63-67, 1992.
5. Danilos J., Zbroja-Sontag W., Baran E., Kutylcio L., Kondratowicz L., Jusiak L. Preliminary studies on the effect of Ukrain (Tris{2-[[5bS-(5ba,6b,12ba)]-5b,6,7,12b,13,14-Hexahydro-13-methyl[1,3] benzodioxolo[5,6c]-1,3-dioxolo[4,5-i] phenanthridinium-56-ol]-Ethaneaminyl}Phosphinesulfide. 6HCL) on the immunological response in patients with malignant tumours. Drugs Exptl. Clin. Res. XVIII (Suppl.), 55-62,1992.
6. Bruller W. Studies concerning the effect of Ukrain in vivo and in vitro. Drugs Exptl. Clin. Res., XVIII (Suppl.), 13-16, 1992.
7. Liepins A., Nowicky J.W. Ukrain is selectively cytostatic and/or cytotoxic to human tumour and HIV-infected cells but not to human normal cells. Recent Advances in Chemotherapy, Anticancer Section. Proceedings of the 17th International Congress of Chemotherapy, Berlin, 1991 (Abstract 2660).
8. Hohenwarter O., Strutzenberger K., Katinger H., Liepins A., Nowicky J.W. Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain. Drugs Exptl. Clin. Res., XVIII (Suppl.), 1-4, 1992.
9. Nowicky J.W., Greit M., Hamler F., Hiesmayr W., Staub W. Macroscopic UV-marking through affinity. J. Tumor Marker Oncol., 33, 463, 1988.
10. Liepins A., Nowicky J.W. Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: Ukrain. Int. J. Immunopharmacol., 14, 1437-1442, 1992.
11. Berger D.P. et al. The clonogenic assay with human tumor xenografts: evaluation, predictive value and application for drug screening. Ann. Oncol., 1, 333-341, 1990.